Bali Peptide Lab vs BioRelix: Tirzepatide & GHK-Cu Prices

If you are comparing Tirzepatide 10 mg prices in Bali or looking for GHK-Cu 100 mg local stock, Bali Peptide Lab and BioRelix publish directly comparable labelled presentations. BPL has the lower reviewed base price for both. The useful next question is whether each supplier's exact material, documentation and fulfilment arrangements meet your laboratory's purchasing requirements.

A lower listed cost for the same labelled amount

For Tirzepatide 10 mg, the reviewed base-price difference is IDR 1,862,100 per vial. For GHK-Cu 100 mg, it is IDR 1,023,800. These figures subtract BPL's listed price from BioRelix's listed price; they do not compare different strengths, assume a monthly supply or translate the amount into personal doses.

The amounts in the table are before promotions and any order-specific adjustments. Matching the label is only the beginning of a procurement comparison: identity, actual quantity, applicable analytical results and the offered batch still need review. A larger price gap is not evidence that two materials have identical quality, and it is not evidence that either supplier's material is unsuitable.

Keep the two documentation approaches visible

BPL's Tirzepatide 10 mg page links a supplied Janoshik report for review. BioRelix advertises an online lot-number report lookup and lot-matched documentation. That is a relevant feature in its favour when a buyer wants to inspect a specific lot. This article does not independently authenticate either supplier's reports or inspect a delivered vial.

BPL's practical strength is that the Tirzepatide listing brings its price, stock indicator and available report into the same purchasing route. Open the report, read the identified sample and ask the team how it relates to the batch offered. For GHK-Cu or any other listing, check documentation separately instead of carrying an assumption across from Tirzepatide.

A later published cutoff for eligible Bali orders

BPL publishes a before-5-PM Bali-time cutoff, while BioRelix advertises before 2 PM WITA. A later cutoff can be useful when an order is confirmed in the afternoon. It does not prove a faster courier journey. BioRelix also advertises cold-chain fulfilment; this comparison does not assert that BPL provides an equivalent temperature-controlled service.

When BPL is the better fit

Choose BPL for a purchasing enquiry when the reviewed lower base prices and the later dispatch eligibility window match your priorities. Send the exact product link, vial count and receiving destination to the team, and confirm the current quote before payment. If your protocol requires particular transport conditions or batch evidence, settle those requirements explicitly before selecting a supplier.

This is a supplier comparison for laboratory research procurement. Tirzepatide and GHK-Cu listings are not personal treatment recommendations, and the price table does not establish clinical equivalence or suitability for human use.